InMed Pharmaceuticals Inc. (INM)

InMed Pharmaceuticals Revenue

In the fiscal year ending June 30, 2025, InMed Pharmaceuticals had annual revenue of $4.94M with 7.50% growth. InMed Pharmaceuticals had revenue of $1.30M in the quarter ending June 30, 2025, with 1.69% growth.

• Revenue (ttm): $4.94M
• Revenue Growth: +7.50%
• P/S Ratio: 0.45
• Revenue / Employee: $380,203
• Employees: 13
• Market Cap: 5.87M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	4.94M	344.90K	7.50%
Jun 30, 2024	4.60M	462.17K	11.18%
Jun 30, 2023	4.14M	3.05M	279.61%
Jun 30, 2022	1.09M	-	-
Jun 30, 2021	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.